2[3]Beatner KR,Spruance,SL,Hongharm AJ,et al.Treatment of genital warts with an immune-response modifier (Imiquimod)[J].J Am Acad Dermatol,1998,38:230.
3[4]Vilata JJ,Sierra X.Efficacy of imiquimod 5% cream in treating genital and perianal warts[J].Ann Dermatol Venerol,2002,129:1.
4Seheffner M, Huibregtse JM, Vierstra RD, et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 [J]. Cell, 1993,75(3) :495- 505.
5Gao Q, Srinivasan S, Boyer SN, et al. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation [J]. Mol Cell Biol, 1999,19(1) : 733- 744.
6Chen LP, Thomas EK, Hu SL, et al. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen [J]. Proc Natl Acad Sci USA, 1991, 88(1):110-114.
7Barbosa MS, Vass WC, Lowy DR, et al. In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential [J]. J Virol,1991,65(1):292-298.
8Baud D, Ponci F, Bobst M, et al. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1 [J]. J Virol, 2004,78(23) : 12901- 12909.
9Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women., a randomised double-blind placebo-controlled multicentre phase Ⅱ efficacy trial [J]. Lancet Oncol, 2005,6(5) :271-278.
10Ault KA, Giuliano AR, Edwards RP, et al. A phase Ⅰ study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine[J]. Vaccine, 2004, 22(23- 24) : 3004- 3007.
9ZARUBA K, GROB PJ, BOLLA K. Thymopentin as adjuvant therapy to hepatitis B vaccination in formerly non-or hyporespond- ing hemodialysis patients [ J ]. Surv lmmunol Res, 1985,4 ( Suppl 1) :102 - 106.
10GROB PJ, BINSWANGER U, BLUMBERGA, etal. Thymo- pentin as adjuvant to hepatitis B vaccination. Results from three double-blind studies[ J]. Sarv lmmunol Res, 1985, 4 (Suppl 1) :S107 - $115.
